Form 8-K - Current report:
SEC Accession No. 0000310158-25-000047
Filing Date
2025-09-09
Accepted
2025-09-09 16:33:09
Documents
22
Period of Report
2025-09-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrk-20250909.htm   iXBRL 8-K 43401
2 EX-4.1 exhibit41-8xk0925.htm EX-4.1 141165
3 EX-4.2 exhibit42-8xk0925.htm EX-4.2 89609
4 EX-4.3 exhibit43-8xk0925.htm EX-4.3 91449
5 EX-4.4 exhibit44-8xk0925.htm EX-4.4 88125
6 EX-4.5 exhibit45-8xk0925.htm EX-4.5 92169
7 EX-4.6 exhibit46-8xk0925.htm EX-4.6 92366
8 EX-5.1 exhibit51-0925.htm EX-5.1 9372
13 sofr.jpg GRAPHIC 15263
14 sofrindex.jpg GRAPHIC 12035
  Complete submission text file 0000310158-25-000047.txt   996462

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20250909.xsd EX-101.SCH 3820
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20250909_def.xml EX-101.DEF 18177
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20250909_lab.xml EX-101.LAB 34044
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20250909_pre.xml EX-101.PRE 19215
24 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20250909_htm.xml XML 8349
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 251303680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)